Eike Steinmann
#164,814
Most Influential Person Now
Researcher
Eike Steinmann's AcademicInfluence.com Rankings
Eike Steinmanncomputer-science Degrees
Computer Science
#9794
World Rank
#10275
Historical Rank
Machine Learning
#4380
World Rank
#4430
Historical Rank
Artificial Intelligence
#4733
World Rank
#4796
Historical Rank
Database
#6750
World Rank
#6988
Historical Rank
Download Badge
Computer Science
Why Is Eike Steinmann Influential?
(Suggest an Edit or Addition)Eike Steinmann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents (2020) (2998)
- Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. (2006) (784)
- Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses (2006) (467)
- Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea (2013) (406)
- Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions (2007) (380)
- Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols (2020) (283)
- Susceptibility of SARS-CoV-2 to UV irradiation (2020) (270)
- The green tea polyphenol, epigallocatechin‐3‐gallate, inhibits hepatitis C virus entry (2011) (259)
- Anti-infective Properties of the Golden Spice Curcumin (2019) (234)
- Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes (2010) (224)
- Structural and Functional Characterization of Nonstructural Protein 2 for Its Role in Hepatitis C Virus Assembly* (2008) (179)
- Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells (2013) (151)
- Efficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles (2008) (140)
- Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients (2020) (140)
- Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus (2007) (139)
- In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome (2016) (136)
- NMR Structure and Ion Channel Activity of the p7 Protein from Hepatitis C Virus* (2010) (135)
- Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2 (2020) (122)
- Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A (2009) (118)
- Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses (2017) (116)
- Clinical course of infection and viral tissue tropism of hepatitis C virus–like nonprimate hepaciviruses in horses (2015) (114)
- Hepatitis C Virus p7 is Critical for Capsid Assembly and Envelopment (2013) (113)
- The impact of hepatitis E in the liver transplant setting. (2014) (105)
- Inactivation and survival of hepatitis C virus on inanimate surfaces. (2011) (100)
- Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2 (2020) (97)
- Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. (2009) (95)
- Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease (2021) (94)
- LY6E impairs coronavirus fusion and confers immune control of viral disease (2020) (91)
- Temperature-dependent surface stability of SARS-CoV-2 (2020) (91)
- Extra‐hepatic replication and infection of hepatitis E virus in neuronal‐derived cells (2016) (86)
- How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides. (2010) (86)
- LY6E impairs coronavirus fusion and confers immune control of viral disease (2020) (84)
- Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. (2011) (81)
- Natural reservoirs for homologs of hepatitis C virus (2014) (80)
- Glucocorticosteroids increase cell entry by hepatitis C virus. (2010) (79)
- Characterization of Determinants Important for Hepatitis C Virus p7 Function in Morphogenesis by Using trans-Complementation (2009) (78)
- Virucidal efficacy of different oral rinses against SARS-CoV-2. (2020) (69)
- Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation (2015) (69)
- Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. (2005) (68)
- Virucidal Activity of World Health Organization–Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses (2017) (63)
- Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes (2020) (63)
- Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment. (2013) (62)
- Inactivation of murine norovirus by chemical biocides on stainless steel (2009) (60)
- Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication (2016) (59)
- The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo (2018) (57)
- Hepatitis C Virus P7—A Viroporin Crucial for Virus Assembly and an Emerging Target for Antiviral Therapy (2010) (57)
- Two pathogen reduction technologies—methylene blue plus light and shortwave ultraviolet light—effectively inactivate hepatitis C virus in blood products (2013) (55)
- Subcellular Localization and Function of an Epitope-Tagged p7 Viroporin in Hepatitis C Virus-Producing Cells (2012) (53)
- Cell culture systems for the study of hepatitis E virus (2019) (50)
- Stem cell-derived polarized hepatocytes (2020) (48)
- Robust hepatitis E virus infection and transcriptional response in human hepatocytes (2020) (48)
- Development and virucidal activity of a novel alcohol-based hand disinfectant supplemented with urea and citric acid (2016) (48)
- Hepatitis E Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV Infection. (2016) (46)
- Persistence of Pathogens on Inanimate Surfaces: A Narrative Review (2021) (45)
- Comparison of virucidal activity of alcohol-based hand sanitizers versus antimicrobial hand soaps in vitro and in vivo. (2012) (45)
- Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations (2016) (44)
- Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria (2016) (44)
- Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global Health (2020) (44)
- Host cell mTORC1 is required for HCV RNA replication (2015) (44)
- Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design (2015) (43)
- Inactivation of hepatitis C virus infectivity by human breast milk. (2013) (43)
- Virucidal activity of 2 alcohol-based formulations proposed as hand rubs by the World Health Organization. (2010) (42)
- Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents (2017) (41)
- Immune protection against reinfection with nonprimate hepacivirus (2017) (40)
- Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse. (2018) (40)
- Mechanisms of Methods for Hepatitis C Virus Inactivation (2014) (39)
- Corrigendum to “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents” [J Hosp Infect 104 (2020) 246–251] (2020) (37)
- Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany (2018) (37)
- Cell culture systems for hepatitis C virus. (2013) (36)
- Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys (2016) (36)
- Hepatitis C virus enters human peripheral neuroblastoma cells – evidence for extra‐hepatic cells sustaining hepatitis C virus penetration (2011) (35)
- Hepatitis E virus replication and interferon responses in human placental cells (2018) (35)
- Frequent presence of hepaci and pegiviruses in commercial equine serum pools. (2016) (35)
- Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols (2020) (35)
- Effects of Green Tea Compound Epigallocatechin-3-Gallate against Stenotrophomonas maltophilia Infection and Biofilm (2014) (35)
- Multiplex PCR for Rapid and Improved Diagnosis of Bloodstream Infections in Liver Transplant Recipients (2012) (34)
- Antiviral Meroterpenoid Rhodatin and Sesquiterpenoids Rhodocoranes A-E from the Wrinkled Peach Mushroom, Rhodotus palmatus. (2019) (34)
- SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay (2021) (34)
- Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication. (2012) (32)
- Value of multiplex PCR using cerebrospinal fluid for the diagnosis of ventriculostomy-related meningitis in neurosurgery patients (2014) (32)
- Completion of Hepatitis C Virus Replication Cycle in Heterokaryons Excludes Dominant Restrictions in Human Non-liver and Mouse Liver Cell Lines (2011) (32)
- Leitlinie der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten (DVV) e. V. und des Robert Koch-Instituts (RKI) zur Prüfung von chemischen Desinfektionsmitteln auf Wirksamkeit gegen Viren in der Humanmedizin (2015) (31)
- Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex (2018) (31)
- Why all blood donations should be tested for hepatitis E virus (HEV) (2019) (29)
- Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission (2016) (28)
- Hepatitis E Virus Drug Development (2019) (28)
- The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression (2021) (28)
- Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 (2021) (28)
- Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. (2013) (28)
- In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis (2013) (28)
- Inactivation of Zika virus in human breast milk by prolonged storage or pasteurization. (2017) (27)
- Evaluation of the virucidal efficacy of disinfectant wipes with a test method simulating practical conditions (2019) (26)
- Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation (2016) (26)
- Vertical transmission of hepatitis C virus-like non-primate hepacivirus in horses. (2016) (24)
- Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry (2017) (24)
- Hepatitis E: An update on One Health and clinical medicine (2021) (23)
- Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study. (2020) (23)
- Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance. (2014) (23)
- Characterization of Hepatitis C Virus Intra- and Intergenotypic Chimeras Reveals a Role of the Glycoproteins in Virus Envelopment (2013) (23)
- Virus–Host Cell Interplay during Hepatitis E Virus Infection (2020) (23)
- Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice (2018) (22)
- C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle. (2020) (22)
- Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 (2021) (22)
- Control of Hepatitis C Virus Replication in Mouse Liver-Derived Cells by MAVS-Dependent Production of Type I and Type III Interferons (2015) (20)
- Characterization of Equine Parvovirus in Thoroughbred Breeding Horses from Germany (2019) (20)
- Membranous Budd–Chiari syndrome in Caucasians (2010) (20)
- Six Heterocyclic Metabolites from the Myxobacterium Labilithrix luteola (2018) (20)
- A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets (2021) (20)
- In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease (2021) (19)
- Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure. (2015) (19)
- COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a++ (2020) (19)
- Frequent occurrence of nonprimate hepacivirus infections in Thoroughbred breeding horses - A cross-sectional study for the occurrence of infections and potential risk factors. (2017) (18)
- Acute and chronic infections with nonprimate hepacivirus in young horses (2016) (18)
- Cytotoxic, antimicrobial and antiviral secondary metabolites produced by the plant pathogenic fungus Cytospora sp. CCTU A309. (2019) (18)
- Active equine parvovirus‐hepatitis infection is most frequently detected in Austrian horses of advanced age (2020) (18)
- Supercritical fluid extraction of heather (Calluna vulgaris) and evaluation of anti-hepatitis C virus activity of the extracts. (2015) (18)
- Thermostability of seven hepatitis C virus genotypes in vitro and in vivo (2013) (18)
- Comparison of Different In Situ Hybridization Techniques for the Detection of Various RNA and DNA Viruses (2018) (17)
- Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds. (2020) (17)
- Extra-Hepatic Replication and Infection of Hepatitis E Virus in Neuronal-Derived Cells (2016) (17)
- Chronic equine hepacivirus infection in an adult gelding with severe hepatopathy (2019) (16)
- Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants. (2019) (16)
- Pasteurization Inactivates SARS-CoV-2–Spiked Breast Milk (2020) (16)
- Equine Parvovirus-Hepatitis Frequently Detectable in Commercial Equine Serum Pools (2019) (16)
- Clinical Outcome and Viral Genome Variability of Hepatitis B Virus–Induced Acute Liver Failure (2019) (16)
- Specific Acquisition of Functional CD59 but Not CD46 or CD55 by Hepatitis C Virus (2012) (15)
- Prevention strategies for blood‐borne viruses—in the Era of vaccines, direct acting antivirals and antiretroviral therapy (2016) (15)
- Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient (2020) (15)
- A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes (2021) (15)
- Virucidal activity of different alcohols against murine norovirus, a surrogate of human norovirus. (2011) (15)
- Guideline for testing chemical disinfectants regarding their virucidal activity within the field of human medicine (2020) (15)
- Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice (2020) (15)
- Absence of cGAS-mediated type I IFN responses in HIV-1–infected T cells (2020) (14)
- Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing (2015) (14)
- Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes (2021) (14)
- Virucidal efficacy of peracetic acid for instrument disinfection (2017) (14)
- Comparison of the in vitro-efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476 (2020) (14)
- Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C (2021) (13)
- Frequent detection of HCV RNA and HCVcoreAg in stool of patients with chronic hepatitis C. (2016) (13)
- Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2. (2021) (13)
- Virucidal activity of Formulation I of the World Health Organization's alcohol-based handrubs: impact of changes in key ingredient levels and test parameters (2013) (13)
- High Environmental Stability of Hepatitis B Virus and Inactivation Requirements for Chemical Biocides (2018) (13)
- Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs (2016) (13)
- Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection (2022) (12)
- Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region. (2014) (12)
- Biotechnological Potential of Bacteria Isolated from the Sea Cucumber Holothuria leucospilota and Stichopus vastus from Lampung, Indonesia (2019) (12)
- Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2 (2021) (12)
- Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor (2019) (12)
- Anti-Infective and Antiviral Activity of Valinomycin and Its Analogues from a Sea Cucumber-Associated Bacterium, Streptomyces sp. SV 21 (2021) (12)
- Antiviral 4-Hydroxypleurogrisein and Antimicrobial Pleurotin Derivatives from Cultures of the Nematophagous Basidiomycete Hohenbuehelia grisea (2018) (12)
- Mitteilung der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten e. V. (DVV) und des Robert Koch-Instituts (RKI) zur Veröffentlichung der aktualisierten Fassung der Leitlinie zur Prüfung von chemischen Desinfektionsmitteln auf Wirksamkeit gegen Viren in der Humanmedizin (Suspensionstest) – F (2015) (11)
- First detection and frequent occurrence of Equine Hepacivirus in horses on the African continent. (2018) (11)
- [Guideline of the German Association for the Control of Viral Diseases (DVV) eV and the Robert Koch Institute (RKI) for testing chemical disinfectants for effectiveness against viruses in human medicine. Version of 1 December, 2014]. (2015) (11)
- The association of Equine Parvovirus-Hepatitis (EqPV-H) with cases of non-biologic-associated Theiler's disease on a farm in Ontario, Canada. (2020) (11)
- Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2 (2020) (11)
- Hepatitis E virus persists in the ejaculate of chronically infected men. (2021) (11)
- Efficient Virus Assembly, but Not Infectivity, Determines the Magnitude of Hepatitis C Virus-Induced Interferon Alpha Responses of Plasmacytoid Dendritic Cells (2014) (10)
- Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis. (2013) (10)
- Virucidal efficacy of a sonicated hydrogen peroxide system (trophon® EPR) following European and German test methods (2017) (10)
- Virucidal gargling and virucidal nasal spray (2021) (10)
- A hepatitis B virus causes chronic infections in equids worldwide (2021) (10)
- Nanoscale copper and silver thin film systems display differences in antiviral and antibacterial properties (2022) (10)
- Skeletocutins A-L: Antibacterial Agents from the Kenyan Wood-inhabiting Basidiomycete, Skeletocutis sp. (2019) (10)
- Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis (2020) (10)
- No Evidence of Mosquito Involvement in the Transmission of Equine Hepacivirus (Flaviviridae) in an Epidemiological Survey of Austrian Horses (2019) (10)
- Prolonged survival of hepatitis C virus in the anesthetic propofol. (2011) (9)
- Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body Fluids (2018) (9)
- Mouthrinses against SARS-CoV-2 – High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial (2022) (9)
- Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients (2021) (9)
- Catch Me (If You Can): Assessing the Risk of SARS-CoV-2 Transmission Via Euro Cash (2021) (9)
- Antiviral Effect of Budesonide against SARS-CoV-2 (2021) (9)
- The Novel Immunosuppressive Protein Kinase C Inhibitor Sotrastaurin Has No Pro-Viral Effects on the Replication Cycle of Hepatitis B or C Virus (2011) (9)
- Exacerbation of hepatitis E virus infection during anti-TNFα treatment. (2017) (8)
- Methylene Blue Treatment of Grafts During Cold Ischemia Time Reduces the Risk of Hepatitis C Virus Transmission (2018) (8)
- SARS-CoV-2 Detection Rates from Surface Samples Do Not Implicate Public Surfaces as Relevant Sources for Transmission (2021) (8)
- Lanyamycin, a macrolide antibiotic from Sorangium cellulosum, strain Soce 481 (Myxobacteria) (2018) (8)
- Exophiala dermatitidis isolates from various sources: using alternative invertebrate host organisms (Caenorhabditis elegans and Galleria mellonella) to determine virulence (2018) (8)
- Review article: HCV ? STAT-C era of therapy (2010) (8)
- Cross-order host switches of hepatitis C-related viruses illustrated by a novel hepacivirus from sloths (2020) (7)
- A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks. (2020) (7)
- Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma (2021) (7)
- Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization. (2014) (7)
- Low risk of SARS-CoV-2 transmission by fomites - a clinical observational study in highly infectious COVID-19 patients. (2022) (7)
- Virucidal activity of WHO-recommended formulations against enveloped viruses including Zika, Ebola and emerging Coronaviruses (2017) (7)
- Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches (2010) (7)
- Incorporation of primary patient‐derived glycoproteins into authentic infectious hepatitis C virus particles (2014) (7)
- The suppressive effect that myriocin has on hepatitis C virus RNA replication is independent of inhibition of serine palmitoyl transferase. (2008) (7)
- SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations. (2019) (6)
- Apolipoprotein E polymorphisms and their protective effect on hepatitis E virus replication (2016) (6)
- Intra-host analysis of hepaciviral glycoprotein evolution reveals signatures associated with viral persistence and clearance (2022) (6)
- Imprint of unconventional T‐cell response in acute hepatitis C persists despite successful early antiviral treatment (2021) (6)
- Clinical Course of Infection and Cross-Species Detection of Equine Parvovirus-Hepatitis (2021) (6)
- Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy (2017) (6)
- 333 KINETICS OF HCV CORE ANTIGEN DURING ANTIVIRAL TREATMENT OF ACUTE AND CHRONIC HEPATITIS C AS DETERMINED BY A NOVEL CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (2009) (5)
- Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients (2021) (5)
- 1162 TURMERIC CURCUMIN INHIBITS ENTRY OF ALL HEPATITIS C VIRUS GENOTYPES INTO HUMAN LIVER CELLS (2013) (5)
- Hepatitis E virus is highly resistant to alcohol-based disinfectants. (2022) (4)
- A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function (2022) (4)
- Hepatitis C Virus Stimulates Murine CD8α-Like Dendritic Cells to Produce Type I Interferon in a TRIF-Dependent Manner (2016) (4)
- Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver (2019) (4)
- Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light (2020) (4)
- Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment (2019) (4)
- Virucidal efficacy of an ozone-generating system for automated room disinfection. (2021) (4)
- Virucidal efficacy of glutaraldehyde for instrument disinfection (2020) (4)
- Alcohol hand rub or soap and water for removal of norovirus from hands - the debate continues. (2015) (4)
- High tolerance of hepatitis B virus to thermal disinfection. (2019) (4)
- Stability and transmission of hepatitis C virus in different anesthetic agents. (2013) (4)
- Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7 (2016) (4)
- 48 ENHANCEMENT OF HEPATITIS C VIRUS ENTRY BY STEROIDS (2009) (4)
- Detection of SARS‐CoV‐2‐specific memory B cells to delineate long‐term COVID‐19 immunity (2021) (4)
- Initial Hepatitis C Virus Infection of Adult Hepatocytes Triggers a Temporally Structured Transcriptional Program Containing Diverse Pro- and Antiviral Elements (2021) (3)
- Low Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission by Fomites: A Clinical Observational Study in Highly Infectious Coronavirus Disease 2019 Patients (2022) (3)
- Analysis of Serine Codon Conservation Reveals Diverse Phenotypic Constraints on Hepatitis C Virus Glycoprotein Evolution (2013) (3)
- Susceptibility of Chikungunya Virus to Inactivation by Heat and Commercially and World Health Organization-Recommended Biocides (2018) (3)
- In vitro activity of active ingredients of disinfectants against drug-resistant fungi. (2019) (3)
- Holder Pasteurization Inactivates SARS-CoV-2 in Human Breast Milk (2020) (3)
- Influence of Tattoo Ink on Hepatitis C Virus Infectiousness (2019) (3)
- Significant compartment‐specific impact of different RNA extraction methods and PCR assays on the sensitivity of hepatitis E virus detection (2021) (3)
- Recommendation of the German Society of Hospital Hygiene (DGKH): Prevention of COVID-19 by virucidal gargling and virucidal nasal spray – updated version April 2022 (2022) (3)
- A novel method to determine the antiviral efficacy of hand rubs using murine norovirus (MNV) as surrogate of human norovirus (2011) (3)
- Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems (2022) (2)
- Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro. (2012) (2)
- Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infection (2021) (2)
- A realistic touch-transfer method reveals low risk of transmission for SARS-CoV-2 by contaminated coins and bank notes (2021) (2)
- Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication. (2022) (2)
- The Heat Stability of Hepatitis B Virus: A Chronological Review From Human Volunteers and Chimpanzees to Cell Culture Model Systems (2020) (2)
- Ecological and Pharmacological Activities of Polybrominated Diphenyl Ethers (PBDEs) from the Indonesian Marine Sponge Lamellodysidea herbacea (2021) (2)
- P209: Near full‐length hepatitis E virus genome sequencing analysis in a chronically infected patient following ribavirin treatment failure (2015) (2)
- Risk assessment of banknotes as a fomite of SARS‐CoV‐2 in cash payment transactions (2021) (2)
- Experimental cross-species infection of donkeys with equine hepacivirus and analysis of host immune signatures (2022) (1)
- Infectivity and stability of hepatitis C virus in different perfusion solutions (2019) (1)
- Successful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvir (2017) (1)
- [Interdisciplinary Perspectives on the Role of Aerosol Transmission in SARS-CoV-2 Infections]. (2022) (1)
- Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim. (2022) (1)
- P0606 : TNF-alpha significantly inhibits hepatitis E virus replication (2015) (1)
- Desinfektionsmittel in der COVID-19-Pandemie: eine Herausforderung (2021) (1)
- Hepatitis E virus species barriers: seeking viral and host determinants. (2022) (1)
- SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a widely used commercial multiplex PCR assay (2021) (1)
- Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elements (2021) (1)
- P096: Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication via blockage of membranous web formation (2015) (1)
- Virucidal activity of Formulation I of the World Health Organization's alcohol-based handrubs: impact of changes in key ingredient levels and test parameters (2013) (1)
- Dose-Dependent Hepacivirus Infection Reveals Linkage between Infectious Dose and Immune Response (2022) (1)
- Two methods of heterokaryon formation to discover HCV restriction factors. (2012) (1)
- Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector (2022) (1)
- Einsatz geeigneter Desinfektionsmitteln bei gentechnisch veränderten Viren und viralen Vektoren – Stellungnahme der Kommission für Virusdesinfektion der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten (DVV) e. V. und der Gesellschaft für Virologie (GfV) e. V. (2020) (1)
- [Hepatitis C virus cell culture models--new perspectives for research and clinic]. (2008) (1)
- Copper and silver thin film systems display differences in antiviral and antibacterial properties -- implications for the prevention of SARS-CoV-2 infections (2021) (1)
- First robust cell culture model for the hepatitis E virus (2020) (0)
- Intra-host diversity of hepatitis E virus polymerase during sofosbuvir treatment (2023) (0)
- Risk of SARS-CoV-2 transmission by fomites: a clinical observational study in highly infectious COVID-19 patients (2022) (0)
- BASIC—LIVER, PANCREAS, AND BILIARY TRACT Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus (2010) (0)
- Inactivation of Hepatitis C Virus by Human Breastmilk (2013) (0)
- Hepatitis E virus is effectively inactivated by methylene blue plus light treatment (2022) (0)
- Taxonomic Characterization, Antiviral Activity and Induction of Three New Kenalactams in Nocardiopsis sp. CG3 (2022) (0)
- Hepatitis E ORF2 Antigen Levels Differentiate between Acute and Chronic Course of Infection (2016) (0)
- 772 SINGLE NUCLEOTIDE POLYMORPHISMS IN HUMAN CYCLOPHILIN A AND THEIR INFLUENCE ON HCVRNA REPLICATION IN VITRO (2011) (0)
- Genotype-specific expression system of Hepatitis C Virus glycoproteins for efficient viral particle complementation (2013) (0)
- Students in Dormitories Were Not Major Drivers of the Pandemic during Winter Term 2020/2021: A Cohort Study with RT-PCR and Antibody Surveillance in a German University City (2021) (0)
- Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients (2022) (0)
- NO EVIDENCE FOR DRUG RESISTANCE BY IMINOSUGAR-BASED HCV ASSEMBLY INHIBITORS IN TISSUE CULTURE (2010) (0)
- Akut- und Langzeitimmunität – was serologische Tests wirklich über den Immunstatus preisgeben (2021) (0)
- CULTURE LONG-TERM TREATMENT WITH IMINOSUGARS-BASED HCV ASSEMBLY INHIBITORS DOES NOT LEAD TO VIRAL BREAKTHROUGH IN TISSUE CULTURE (2011) (0)
- Janus kinase inhibitors modulate hepatitis E virus infection (2023) (0)
- 1147 EFFECT OF GENETIC POLYMORPHISMS IN THE CD81 GENE ON HEPATITIS C VIRUS CELL ENTRY AND NEUTRALIZATION WITH ANTI-CD81 ANTIBODIES (2013) (0)
- Chapter 2 Cell Culture Systems for Hepatitis C Virus (2013) (0)
- Risk Stratification of SARS-CoV-2 Breakthrough Infections Based on an Outbreak at a Student Festive Event (2022) (0)
- Erratum to: Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2 (2020) (0)
- Breakthrough Infections with SARS-CoV-2 in Vaccinated Students After a Festive Event - Identification of Risk Factors (2021) (0)
- The impact of adipokines hormones on HCV life-cycle (2014) (0)
- Functional Characterization of the Hepatitis C p7 protein in S. cerevisiae (2007) (0)
- Efficient Inactivation of Monkeypox Virus by World Health Organization‒Recommended Hand Rub Formulations and Alcohols (2022) (0)
- Stem cell-derived polarized hepatocytes (2020) (0)
- Survival and inactivation of hepatitis E virus on inanimate surfaces. (2023) (0)
- An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus Inoculation (2022) (0)
- 419 INACTIVATION OF HEPATITIS C VIRUS BY DISINFECTANTS AND HEAT (2009) (0)
- Exophiala dermatitidis isolates from various sources: using alternative invertebrate host organisms (Caenorhabditis elegans and Galleria mellonella) to determine virulence (2018) (0)
- 40 COMPLETION OF HEPATITIS C VIRUS REPLICATION CYCLE IN HETEROKARYONS EXCLUDES DOMINANT RESTRICTION FACTORS IN HUMAN NON-LIVER AND MOUSE LIVER CELL LINES (2011) (0)
- 80 CHARACTERIZATION OF DETERMINANTS IMPORTANT FOR GLYCOPROTEIN FUNCTION IN HEPATITIS C VIRUS (HCV) MORPHOGENESIS USING TRANS- COMPLEMENTATION (2009) (0)
- Impact of low eGFR on the immune response against COVID-19 (2022) (0)
- Evaluation of the virucidal efficacy of disinfectant wipes with a test method simulating practical conditions (2019) (0)
- 866 INACTIVATION OF HEPATITIS C VIRUS BY HUMAN MOTHER'S MILK (2012) (0)
- Significant compartment-specific impact of the RNA extraction and quantification method on the sensitivity of hepatitis E virus detection: implications for clinical care? (2020) (0)
- P199: Mutational analysis of hepatitis E virus ORF1 ‘X‐domain’ identifies an evolutionary conserved macrodomain protein/Appr‐1''‐pase active‐site, critical for viral RNA replication in hepatoma cells (2015) (0)
- In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant (2022) (0)
- Relevance of HEV detection in ejaculate of chronically infected patients (2022) (0)
- Hepatitis E virus replication and interferonresponse in human placental-derived cells (2018) (0)
- AB1452 EVALUATION OF HEPATITIS E VIRUS INFECTION DURING JAK INHIBITOR THERAPY IN AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES (2022) (0)
- European College of Equine Internal Medicine consensus statement on equine flaviviridae infections in Europe (2022) (0)
- Interdisziplinäre Perspektiven zur Bedeutung der Aerosolübertragung für das Infektionsgeschehen von SARS-CoV-2 (2022) (0)
- Thermo-stability of seven Hepatitis C virus genotypes in vitro and in vivo (2013) (0)
- P215: Exacerbation of hepatitis E virus infection during anti‐TNFα treatment (2015) (0)
- P211 HOST mTORC1 SIGNALING IS REQUIRED FOR HEPATITIS C VIRUS (HCV) RNA REPLICATION (2014) (0)
- Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation (2016) (0)
- Active human complement reduced the titer of Zikaviruses via formation of the membrane-attack complex (2018) (0)
- Virucidal potential of oral rinses and nasal sprays against SARS-COV-2 and their mode of action (2021) (0)
- Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes (cid:1) § (2010) (0)
- Expanding the donor pool-decontamination of HCV RNA positive kidneys with methylene blue (2018) (0)
- Relevance of microRNAs in SARS-CoV-2 infection of primary human hepatocytes (2023) (0)
- Exacerbation d’infection par le virus de l’hépatite E au cours d’un traitement par anti-TNFα (2017) (0)
- IMMUNOSUPPRESSIVE AGENTS AND THEIR INFLUENCE ON HCV RNA REPLICATION AND INFECTIVITY IN VITRO: 1942 (2008) (0)
- Epidermal growth factor receptor modulates hepatitis e virus entry in human hepatocytes -HEP-22-1113. (2023) (0)
- Infection of young foals with Equine Parvovirus-Hepatitis following a fatal non-biologic case of Theiler's disease. (2022) (0)
- Sterilization procedures for CO2 incubators (2018) (0)
- Stability and inactivation of monkeypox virus on inanimate surfaces. (2023) (0)
- High tolerance of hepatitis E virus towards alcohol-based disinfectants (2022) (0)
- Histologische Befunde bei equiner Hepacivirusinfektion (2019) (0)
- ASIC — LIVER , PANCREAS , AND BILIARY RACT lucocorticosteroids Increase Cell Entry by Hepatitis C Virus (0)
- 111 NEW APPROACH FOR THE IDENTIFICATION OF REPLICATION COMPETENT HCV ISOLATES DERIVED FROM PATIENT SERA (2010) (0)
- Virucidal efficacy of peracetic acid for instrument disinfection (2017) (0)
- P233 THE NATURAL COMPOUND PENTA-O-GALLOYL-GLUCOSE, DERIVED FROM THE ROOT CORTEX MOUTAN, EFFICIENTLY INHIBITS HEPATITIS C-VIRUS ENTRY AND SHOWS EXCELLENT PHARMACOKINETIC PERFORMANCE IN VIVO (2014) (0)
- P114: Immunoglobulin purified from antibody associated virus from hepatitis C viraemic sera exhibit selective targeting of homologous HCV genotype (2015) (0)
- Reply: PCR assay for pathogen detection in ventriculostomy-related meningitis in neurosurgery patients: unanswered questions? (2015) (0)
- 10th Annual European College of Equine Internal Medicine Congress: 2—4 November, 2017 (2018) (0)
- Clinical and molecular characterization of the human kidney as extrahepatic site of hepatitis E virus infection (2020) (0)
- Evaluation of the substitution of poliomyelitis virus for testing virucidal activities of instrument and surface disinfection (2022) (0)
- A touch transfer assay to determine surface transmission of highly pathogenic viruses (2022) (0)
- FREE PAPER BASIC SCIENCE O‐10: Hepatitis C virus stimulates murine CD8α‐like dendritic cells to produce type I interferon in a TRIF‐dependent manner (2015) (0)
- P115: Human pDC potentially carrying two alleles with reconstituted IFN‐λ4 gene function show reduced IFN‐ɑ induction upon stimulation with HCV infected hepatoma cells (2015) (0)
- SEC14L2 is not a reliable predictor of HCV replication fitness (2016) (0)
- Hepatitis E Virus—Current Developments in Antiviral Strategies (2021) (0)
- 642 CHARACTERISATION OF HEPATITIS C VIRUS ENTRY AND RNA REPLICATION IN CELLS OF CNS ORIGIN (2010) (0)
- Old and new insights into virucidal effectiveness of hygienic hand disinfection. (2009) (0)
- Taxonomic Characterization, Antiviral Activity and Induction of Three New Kenalactams in Nocardiopsis sp. CG3 (2022) (0)
- Response to Lamarca et al. (2020) (0)
- Automated high-throughput image-based screen discovers members of the Akt serine/threonine kinase family as targets for treatment of HEV virus infection in vitro (2023) (0)
- A novel class of glycan-specific human monoclonal antibodies neutralizing the hepatitis E virus (2022) (0)
- HEV genomic insertions identified in chronic patients enhance viral fitness (2023) (0)
- Impact of concentration, temperature and pH on the virucidal activity of alcohols against human adenovirus. (2023) (0)
- Variants in the human PPIA gene render host cells refractory to hepatitis C virus infection by destabilization of the essential host factor cyclophilin A (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Eike Steinmann?
Eike Steinmann is affiliated with the following schools:
